UK Approves Pfizer-BioNTech Vaccine for Rollout in Days

Today, UK becomes first country to approve Pfizer-BioNTech vaccine for rollout from ‘next week’.

Health Minister Matt Hancock announced on Wednesday that the UK's medicines regulatory agency has given its authorization to the vaccine and that the NHS would be ready to start vaccinating early next week.

Three candidate vaccines have announced promising results from phase three trials in the past month.

Earlier this month, the two companies announced from preliminary results that the vaccine is 95% effective and in particular, is 94% effective in people over the age of 65 who are more at risk of developing severe COVID-19.

“The Emergency Use Authorisation in the UK will mark the first time citizens outside of the trials will have the opportunity to be immunised against COVID-19,” said Ugur Sahin, CEO and co-founder of German company BioNTech.

“We believe that the roll-out of the vaccination program in the U.K. will reduce the number of people in the high-risk population being hospitalised," Sahin added in a statement.

The two companies currently have an agreement with the UK to provide 40 million doses of the vaccine in 2020 and 2021.